Quantifying CDK inhibitor selectivity in live cells
Cyclin-dependent kinase (CDK) inhibitors are widely used both in the clinic and for basic research aimed at dissecting the specific cellular functions of specific CDKs. Here, the authors report the development of a panel of fluorescent reporter probes and provide a comprehensive profile of the inhib...
Guardado en:
Autores principales: | Carrow I. Wells, James D. Vasta, Cesear R. Corona, Jennifer Wilkinson, Chad A. Zimprich, Morgan R. Ingold, Julie E. Pickett, David H. Drewry, Kathryn M. Pugh, Marie K. Schwinn, Byounghoon (Brian) Hwang, Hicham Zegzouti, Kilian V. M. Huber, Mei Cong, Poncho L. Meisenheimer, Timothy M. Willson, Matthew B. Robers |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5ab2cf72cb7f4b5ea0a65e02f4e02daf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor
por: Tigist Y. Tamir, et al.
Publicado: (2020) -
Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2
por: Lindsey R. Pack, et al.
Publicado: (2021) -
Three decades of Cdk5
por: Ping-Chieh Pao, et al.
Publicado: (2021) -
CDK1 phosphorylates WRN at collapsed replication forks
por: Valentina Palermo, et al.
Publicado: (2016) -
The Role of CDK4 in the Pathogenesis of Pancreatic Cancer
por: Emily Jiggens, et al.
Publicado: (2021)